Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines

Drug and Alcohol Dependence

Volumn 142, Issue , 2014, Pages 24-32

  Grossbard, Joel R ^a   Malte, Carol A ^a,b   Saxon, Andrew J ^b,c   Hawkins, Eric J ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Benzodiazepines; Clinical monitoring; Opioid therapy; Substance use disorders; Veterans

Indexed keywords

BENZODIAZEPINE DERIVATIVE; OPIATE; NARCOTIC ANALGESIC AGENT;

ADDICTION; ADULT; AGED; ARTICLE; COMORBIDITY; DRUG SCREENING; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OUTPATIENT CARE; PATIENT MONITORING; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RISK FACTOR; SUBSTANCE ABUSE; SUICIDE; URINALYSIS; COMPLICATION; PAIN; PRIMARY HEALTH CARE; VETERAN;

ADULT; AGED; ANALGESICS, OPIOID; BENZODIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PRIMARY HEALTH CARE; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; VETERANS;

EID: 84905561369     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.03.020     Document Type: Article

References (40)

1. Barker M.J., Greenwood K.M., Jackson M., Crowe S.F. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004, 18:37-48.
2. Bohnert A.S.B., Igen M.A., Ignacio R.V., McCarthy J.F., Valenstein M., Blow F.C. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am. J. Psychiatry 2012, 169:64-70.
3. Braden J.B., Russo J., Fan M.Y., Edlund M.J., Martin B.C., DeVries A., Sullivan M.D. Emergency department visits among recipients of chronic opioid therapy. Arch. Intern. Med. 2010, 170:1425-1432.
4. Chapman C.R., Lipschitz D.L., Angst M.S., Chou R., Denisco R.C., Donaldson G.W., Fine P.G., Foley K.M., Gallagher R.M., Gilson A.M., Haddox J.D., Horn S.D., Inturrisi C.E., Jick S.S., Lipman A.G., Loeser J.D., Noble M., Porter L., Rowbotham M.C., Schoelles K.M., Turk D.C., Volinn E., Von Korff M.R., Webster L.R., Weisner C.M. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J. Pain 2010, 11:807-829.
5. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987, 40:373-383.
6. Chou R. Clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?. Polskie Archiwum. Medycyny. Wewnetrznej. 2009, 119:469-477.
7. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., Donovan M.I., Fishbain D.A., Foley K.M., Fudin J., Gilson A.M., Kelter A., Mauskop A., O'Connor P.G., Passik S.D., Pasternak G.W., Portenoy R.K., Rich B.A., Roberts R.G., Todd K.H., Miaskowski C. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J. Pain 2009, 10:113-130.
8. Darnall B.D., Stacey B.R., Chou R. Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Med. 2012, 13:1181-1211.
9. Department of Veterans Affairs and Department of Defense VA/DoD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain - The Management of Opioid Therapy and Chronic Pain Working Group 2010, http://www.healthquality.va.gov/COT_312_Full-er.pdf (accessed 01.08.13).
10. Dobscha S.K., Morasco B.J., Duckart J.P., Macey T., Deyo R.A. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin. J. Pain 2013, 29:102-108.
11. Gupta D.K., Avram M.J. Rational opioid dosing in the elderly: dose and dosing interval when initiating opioid therapy. Clin. Pharmacol. Ther. 2012, 91:339-343.
12. Harris A.H., Humphreys K., Bowe T., Kivlahan D.R., Finney J.W. Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure. J. Subst. Abuse Treat. 2009, 36:294-305.
13. Hausmann L.R., Gao S., Lee E.S., Kwoh C.K. Racial disparities in the monitoring of patients on chronic opioid therapy. Pain 2013, 154:46-52.
14. Hawkins E.J., Lapham G.T., Kivlahan D.R., Bradley K.A. Recognition and management of alcohol misuse in OEF/OIF and other veterans in the VA: a cross-sectional study. Drug Alcohol Depend. 2010, 109:147-153.
15. Hawkins E.J., Malte C.A., Baer J.S., Kivlahan D.R. Prevalence, predictors, and service utilization of patients with recurrent use of Veterans Affairs substance use disorder specialty care. J. Subst. Abuse Treat. 2012, 43:221-230.
16. Jones C.M., Mack K.A., Paulozzi L.J. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013, 309:657-659.
17. Katz N.P., Adams E.H., Chilcoat H., Colucci R.D., Comer S.D., Goliber P., Grudzinskas C., Jasinski D., Lande S.D., Passik S.D., Schnoll S.H., Sellers E., Travers D., Weiss R. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin. J. Pain 2007, 23:648-660.
18. Morasco B.J., Dobscha S.K. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen. Hosp. Psychiatry 2008, 30:93-99.
19. Morasco B.J., Duckart J.P., Dobscha S.K. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. J. Gen. Intern. Med. 2011, 26:965-971.
20. O'Connell M.J., Kasprow W.J., Rosenheck R.A. The impact of current alcohol and drug use on outcomes among homeless veterans entering supported housing. Psychol. Serv. 2013, 10:241-249.
21. Perron B.E., Bohnert A.S.B., Monsell S.E., Vaughn M.G., Epperson M., Howard M.O. Patterns and correlates of drug-related ED visits: results from a national survey. Am. J. Emerg. Med. 2011, 29:704-710.
22. Peterson J.F., Kuperman G.J., Shek C., Patel M., Avorn J., Bates D.W. Guided prescription of psychotropic medications for geriatric inpatients. Arch. Intern. Med. 2005, 165:802-807.
23. Potter J.S., Prather K., Weiss R.D. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am. J. Addict. 2008, 17:121-125.
24. Price A.M., Ilgen M.A., Bohnert A.S.B. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. J. Subst. Abuse Treat. 2011, 41:208-214.
25. Qin P., Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch. Gen. Psychiatry 2005, 62:427-432.
26. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J.C., Saunders L.D., Beck C.A., Feasby T.E., Ghali W.A. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care 2005, 43:1130-1139.
27. Rosenblum A., Joseph H., Fong C., Kipnis S., Cleland C., Portenoy R.K. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003, 289:2370-2378.
28. Saunders K.W., Von Korff M., Campbell C.I., Banta-Green C.J., Sullivan M.D., Merrill J.O., Weisner C. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J. Pain 2012, 13:266-275.
29. Seal K.H., Cohen G., Waldrop A., Cohen B.E., Maguen S., Ren L. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001-2010: implications for screening, diagnosis and treatment. Drug Alcohol Depend. 2011, 116:93-101.
30. Seal K.H., Shi Y., Cohen G., Cohen B.E., Maguen S., Krebs E.E., Neylan T.C. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA 2012, 307:940-947.
31. Smink B.E., Egberts A.C., Lusthof K.J., Uges D.R., de Gier J.J. The relationship between benzodiazepine use and traffic accidents: a systematic literature review. CNS Drugs 2010, 24:639-653.
32. Smith M.T., Edwards R.R., Robinson R.C., Dworkin R.H. Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased risk. Pain 2004, 111:201-208.
33. Smith D.H., Perrin N., Feldstein A., Yang X., Kuang D., Simon S.R., Sittig D.F., Platt R., Soumerai S.B. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch. Intern. Med. 2006, 166:1098-1104.
34. Starrels J.L., Becker W.C., Weiner M.G., Li X., Heo M., Turner B.J. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J. Gen. Intern. Med. 2011, 26:958-964.
35. StataCorp. Stata Statistical Software: Release Edition 9.0 2007, Stata Corporation, College Station, TX.
36. Warner E.A. Opioids for the treatment of chronic noncancer pain. Am. J. Med. 2012, 125:1155-1161.
37. Warner M., Chen L.H., Makuc D.M. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief 2009, (22):1-8.
38. Weisner C.M., Campbell C.I., Ray G.T., Saunders K., Merrill J.O., Banta-Green C., Sullivan M.D., Silverberg M.J., Mertens J.R., Boudreau D., Von Korff M. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 2009, 145:287-293.
39. White J.M., Irvine R.J. Mechanisms of fatal opioid overdose. Addiction 1999, 94:961-972.
40. Woolcott J.C., Richardson K.J., Wiens M.O., Patel B., Marin J., Khan K.M., Marra C.A. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch. Intern. Med. 2009, 169:1952-1960.